Public Health

Workplace Violence in your workplace; the consequences are many, unpredictable, and can be severe. Injury or death of employees, customers, and/or visitors from workplace violence, resulting in lawsuits, property damage, increased insurance premiums, OSHA enforcement actions, increases employee turnover and reduced community trust.

Overview The US FDA expects that as part of a product development Design Control Program risk management will be conducted. FDA recommends using ISO 14971 as a guide and has accepted it as a recognized standard. One of the techniques described in ISO 14971 is Hazard Analysis. This is the most powerful of the risk management techniques because it considers risks in normal operation as well as fault conditions. FMEA and FTA consider only fault conditions and are more suited as reliability tools than as product safety tools. We will explain how to integrate Human Factors studies into the Hazard Analysis and how to integrate Hazard Analysis into the design program. For more detail please click on this below link: http://bit.ly/2moVzlU Email: referrals@complianceglobal.us Toll Free: +1-844-746-4244 Tel: +1-516-900-5515 Fax: +1-516-900-5510

Accredited self-paced online Medical Coding training. This course covers ICD-10, HCPCS, and CPT and is approved by the AAPC. Students can enroll at any time and complete the course at their pace. Begin learning Medical Coding today!

With all of the deadlines, projects, and tasks that you have to do every day at work, it's hard to find time to set personal development goals that positively impact your work performance and help you to grow professionally. But how will you advance in your career if you don't make time for values clarification, goal setting, and increasing productivity? Without a concrete plan in place, you are at risk of stagnating in your current position and experiencing burnout. Taking a personal retreat is an effective and time-efficient strategy for moving your career forward and recharging your batteries. Perhaps you've never attended a retreat or the last one your workplace had was boring and irrelevant. This two-day seminar will provide the time, information, and processes for you to experience your own personal retreat and identify the individual goals that matter to you and are relevant for your professional and personal development.

Overview: Defining Attribute Agreement Analysis (AAA): A review of basic AAA analysis. Will cover the 3 basic types of agreements: Agreement with oneself, Agreement to a peer, Agreement to the standard. Both the "Statistical AAA" and the Kappa value will be reviewed. Confidence levels for the result bands will also be reviewed. Incorporation of AAA into the Control Plan and frequency of "calibration" will be reviewed. How It Works: Session attendees will observe the step by step actions taken to undergo an AAA and its iterative results. A review of the 3 basic types of agreements will be conducted. Benefits of the Calibrated Human: There are multiple benefits when calibrating the human operator. A pros/cons review will be held discussing the general benefits of reductions in arguments (what is good or not) internal/ external rework, returns, premium freight, etc.

Overview: This session describes what a leading indicator is, how to use it, and how to measure it. We ask ourselves “I know what went wrong because I investigated it and tracked it", but how do I know “what went right." That is a question we all ask ourselves and our clients (the bosses) especially want to know because they have to justify the money spent and the resources allocated to the safety and environmental activities. When we have good months or even good years (the statistics on incidents are low) how do we know why. If the safety statistics or environmental incidents graph shows peaks and dips over the last several years - WHY? If the graph shows a high, then a gradual lowering with a continuous low over several years - WHY? We will discuss how leading indicators are used in other fields and why they can apply to the safety field. We discuss what a leading indicator is NOT and well as what one IS.

Overview: The regulatory process can be mired in opposition derived from NIMBY’s, environmentalists, competitors and a variety of other reasons. You typically have to generate support from within the community in order to counter opponents to your specific development, this can cost time and resources and unless you understand the political nuances, being successful is a difficult task. Depending on the size of your company, you can already have that political force at your fingertips. This force can be unleashed at opportune moments to influence their elected officials in order to get your local, statewide and sometimes federal legislative agenda passed through their constituent voices.

Overview: This topic discusses in detail, the process of how to develop high performance expectations through setting SMART goals and objectives, getting the support you need in order to achieve the goals, and how to measure if the goals are working for you and the company you work for. It is a step-by-step process from defining the objectives, setting up the guiding principles, setting the high performance objectives (HPE), establishing the key accountabilities, working up a development plan, defining the employee and supervisor goals, and setting up the go forward" plan for the actual goal setting processes. We also develop a Goal Matrix" where people can track their progress on a month-to-month basis.

Overview: Before the celebration of a successful clinical development of a novel therapeutic molecule, the teams face several years of challenges with the drug development process. In early drug development when just an idea has been placed on a path to clinical development the project team identifies the possible risk associated with that class of drug. This webinar has been designed to discuss the terminology and definitions of adverse events and to compare the difference between an event and an adverse reaction. Anticipated and unanticipated adverse events will be discussed with examples provided to clarify the differences.

Overview: Medical identity theft is a growing threat in the nefarious world of identity theft. Although it is not as well-known as financial identity theft, the impact of medical identity theft is long-lasting and life-threatening. It affects one in four Americans and accounts for three percent of all identity theft cases, or approximately 500,000 cases per year. With only one arrest made in every 700 cases, medical identity theft costs consumers and businesses nearly $60 billion each year. Price : $139.00 Contact Info: MentorHealth Phone No: 1-800-385-1607 FaX: 302-288-6884 support@mentorhealth.com Event Link: http://bit.ly/Medical-Identity-Theft-and-or-Identity-Theft-and-Health-Care-Fraud http://www.mentorhealth.com/

Overview: Investigational device accountability is outlined in the FDA's regulations. Included in this topic is the receipt, storage, distribution, reconciliation, return and authorized destruction of investigational devices. Many industry sponsors already have standard operating procedures outline these policies but there are instances when a standard operating procedure or guideline does not already exist and those working with these devices need to know their responsibilities. Price : $139.00 Contact Info: MentorHealth Phone No: 1-800-385-1607 FaX: 302-288-6884 support@mentorhealth.com Event Link: http://bit.ly/Investigational-Device-Accountability http://www.mentorhealth.com/

Overview: In this session Mr. Wolfe will provide a general Stark Law overview. He will also discuss best practices for auditing existing space lease arrangements and for implementing new time-share arrangements under the new 2016 Stark rules. Why should you Attend: Given the substantial awards and settlements in recent Stark Law enforcement actions, Stark Law compliance has become more than just a compliance issue: it is an enterprise risk management issue. As medical groups, hospitals, and health systems pursue integration strategies and transition to more innovative hospital-physician arrangements, these organizations must manage their compliance and enterprise risk by ensuring their compensation arrangements are defensible under the Stark Law. Price : $139.00 Contact Info: MentorHealth Phone No: 1-800-385-1607 FaX: 302-288-6884 support@mentorhealth.com Event Link: http://bit.ly/Structuring-Physician-Leases-Under-the-New-2016-Stark-Rules http://www.mentorhealth.com/

Overview: The course includes activities to help trainees develop a general plan and procedures to standardize and control food quality and safety transportation processes. For food shippers, carriers and receivers, standardization or upgrade to current practices is critical. For buyers, knowing how to establish standards for your food transporters sets the stage for required supply chain controls. The journey from "Where do we start?" to "We are compliant food safety carriers." begins here and establishes a basis for meeting newly evolving FSMA food safety during transportation requirements.

Overview: Effective sanitation in the food industry involves the maintenance of clean conditions in the entire food operation. This status is attained through the destruction of residual microorganisms after cleaning of production, storage and service areas of food establishments. As the food processing and foodservice industries have grown, methods of food production, processing, distribution, and preparation have changed. Increased processing and food preparation have included more prepackaged food as partially or fully prepared bulk or pre-portioned servings and centralized food production.

Overview: This webinar will look at the historical use of indicator organisms to define the safety of drinking water and will examine the limitations of this approach for evaluating water potability. Waterborne outbreaks will be reviewed in the context of identifying the wide etiological scope and the inability of traditional indicators to mitigate these risks. Alternate considerations for assessing potability will also be discussed.

Overview: Cleaning and sanitation programme are essential to control the hazards of microbiological and physical contamination of foods in the foodservice and food manufacturing facilities. To ensure that a facility and equipment are clean, sanitised and suitable for their intended use, management of the food business must draw up and operate a written sanitation programme and suitable cleaning procedure for all equipment surfaces and structures within the facility. This webinar will offer the participants unambiguous cleaning and sanitation templates for High care and Low risk areas.

Overview: Root Cause is an essential component for addressing non-conformance. It uses a specific set of steps, with associated tools, to find the primary cause of the problem, so that you can: Determine what happened. Determine why it happened. Figure out what to do to reduce the likelihood that it will happen again. RCA assumes that systems and events are interrelated. An action in one area triggers an action in another, and another, and so on. By tracing back these actions, you can discover where the problem started and how it grew into the symptom you're now facing.

Overview: A combination product is a product composed of any combination of a drug and a device; a biological product and a device; a drug and a biological product; or a drug, device, and a biological product. Under 21 CFR 3.2 (e), a combination product is defined to include: A product comprised of two or more regulated components (i.e., drug/device, biologic/device, drug/biologic, or drug/device/biologic) that are physically, chemically, or otherwise combined or mixed and produced as a single entity.

Since the year 2000 there has been an increasing trend of registered clinical studies from approximately 4,000 in 2000 to 160,000 in 2014. In 2014 Forbes Magazine reported that the FDA had approved 44 drugs the highest in 18 years. As innovation and new technological approaches are applied to the discovery of novel molecules, the number of studies will continue to increase to meet the areas of unmet medical needs and especially rare diseases. Clinical Trial.gov currently list 193,510 studies in 50 states and in 190 countries.

The topic is device clinical trials. This term refers to the use of medical products on/in humans, in order to gain useful knowledge about the product. Such knowledge might be required to enable the development of user instructions, better understanding of limitations, evidence of clinical usefulness, or elements of product design that require additional changes. These trials are very expensive in outlay, personnel time and elapsed time. FDA regulations are designed to ensure that trials conducted in the US are performed with a number of safeguards, not only for the patient undergoing the trial, but for the sponsor of the trial, to ensure that sufficient thought has been given to protocol development, patient safety, definition of endpoints, data analysis, and data integrity.